|1.||Schaper, Roland: 8 articles (08/2013 - 06/2008)|
|2.||Stanneck, Dorothee: 7 articles (01/2014 - 03/2007)|
|3.||Mencke, N: 6 articles (02/2009 - 01/2000)|
|4.||Traversa, Donato: 5 articles (10/2015 - 08/2009)|
|5.||Otranto, Domenico: 5 articles (01/2014 - 03/2007)|
|6.||Capelli, Gioia: 5 articles (01/2014 - 03/2007)|
|7.||Di Cesare, Angela: 4 articles (10/2015 - 08/2009)|
|8.||Cantacessi, Cinzia: 4 articles (01/2013 - 03/2007)|
|9.||Pampurini, Fabrizio: 4 articles (10/2012 - 08/2009)|
|10.||Boari, Andrea: 3 articles (10/2015 - 06/2011)|
11/23/2012 - "This study demonstrated that based on faecal egg count reduction, the spot on combination containing imidacloprid 10% (w/v) and moxidectin 1% (w/v) (Advocate(®)/Advantage(®) Multi, Bayer Animal Health) given at the recommended dose is highly effective against infection with A. "
05/01/2010 - "This study demonstrated that the spot on combination containing imidacloprid 10% and moxidectin 2.5 % (Advocate/Advantage Multi, Bayer Animal Health) given at the recommended dose is highly effective against infection with A. "
08/01/2011 - "Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens."
06/30/2011 - "Given the merit to the new approaches for the control and treatment of this infection, the present study evaluated the efficacy of a single application of the spot-on formulation containing imidacloprid 10%/moxidectin 2.5% (Advocate(®), Bayer Animal Health) in the elimination of D. "
08/01/2013 - "The efficacy of imidacloprid 10 %/moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) against experimental Dirofilaria (D.) repens infection in dogs was evaluated in a blinded, negative controlled randomised laboratory efficacy study. "
08/01/1997 - "To evaluate efficacy of a 9.1% (w/w) imidacloprid solution, applied topically, to remove fleas from dogs and the duration of residual flea control when dogs were exposed to continuing flea infestation. "
09/01/2001 - "The ease of application, absence of toxicity, and long residual effect makes imidacloprid a useful drug for treating flea infestations in these marsupials."
08/01/1997 - "Monthly imidacloprid application of 7.5 to 10 mg/kg will rapidly kill existing and reinfesting flea infestations on dogs and break the flea life cycle by killing adult fleas before egg production begins."
06/01/2011 - "We investigated a newly-developed imidacloprid-treated grain bait that could potentially reduce flea infestations and mitigate the effects of plague on black-tailed prairie dogs (C. "
01/01/2013 - "From March 2011 to April 2012, a field study was conducted in a private shelter in southern Italy to assess the efficacy of the imidacloprid/flumethrin collar against tick and flea infestations and to determine if this strategy would decrease tick-borne pathogen transmission in young dogs. "
|3.||Body Weight (Weight, Body)
01/01/2013 - "Group 1 served as the control, while groups 2 and 4 were administered with imidacloprid (80 mg/kg body weight) daily by oral gavage for 28 days. "
02/01/2009 - "However, acceptable daily intake (ADI) of imidacloprid is 0.06 mg kg(-1) body weight day(-1), which means an adult of 60 kg and a child of 10 kg can safely tolerate intake of 3,600 and 600 microg imidacloprid, respectively, without any appreciable risk to their life. "
06/01/2001 - "One group was treated topically with an imidacloprid spot-on formulation at a dose rate of 10 mg/kg body-weight on Day 0. "
01/01/2000 - "On day 0, 12 dogs (group 1) were treated with imidacloprid at the minimum label dose of 10 mg/kg body weight. "
08/01/1997 - "Flea control with 3.75 mg of imidacloprid/kg of body weight ranged from 94.4 to 96.9% for days 14 to 28 and decreased to 91.6% by 34 days after treatment. "
|4.||Lice Infestations (Pediculosis)
04/01/1999 - "A clinical field trial was performed to evaluate the efficacy of imidacloprid, the active ingredient of Advantage 10% Spot-On, against natural lice infestations on dogs. "
06/01/2008 - "Use of a formulation containing imidacloprid and moxidectin in the treatment of lice infestation in guinea pigs."
06/01/2008 - "Ten guinea pigs infested with Gliricola porcelli were free of adult lice and eggs, and of adverse reactions, 30 days after treatment, with a single application of 0.05 mL of a solution containing 10% (w/v) imidacloprid and 1% (w/v) moxidectin indicating that this procedure is an effective treatment for lice infestations in guinea pigs."
|5.||Bites and Stings (Sting)
09/01/2010 - "Our results indicate the use of a palatable host-targeted bait block containing imidacloprid was an effective technique for quickly reducing flea numbers on rodents in northwest Uganda and, thus, could be useful for lowering the potential risk of human flea bite exposures during plague outbreaks if applied continuously during the period of risk."
07/01/2003 - "The study demonstrated the high repellent potential of the imidacloprid / permethrin combination, thus protecting dogs from sand fly bites."
07/01/2003 - "To prevent dogs from sand fly bites and thus transmission of Leishmania, an imidacloprid 10% w/v / permethrin 50% w/v combination was evaluated for its insecticidal and repellent efficacy. "
05/31/2008 - "Preventing tick bites is a priority to reduce the risk of TBDs and it was the aim of the present study to evaluate the efficacy of a combination of imidacloprid 10% and permethrin 50% (ImPer) (Advantix; Bayer AG, Germany) in a spot-on formulation to control CME under field conditions. "
|7.||Flavin-Adenine Dinucleotide (FAD)